CommercialCoverageMedium impact
Subtalar Arthroereisis
Blue Cross & Blue Shield of Mississippi·Orthopedics, Podiatry·Medical Policy
Effective date
May 7, 2025
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield policy A.7.01.104 continues to classify subtalar arthroereisis procedures as investigational, meaning they are not covered except under Federal Employee Program (FEP) plans where FDA-approved devices may be assessed for medical necessity. The policy was updated to include new FDA-cleared devices but maintains the investigational status.
Action Required
By May 7, 2025: Billing team must update system to flag CPT 28899 and HCPCS S2117 as investigational/non-covered for all Blue Cross Blue Shield plans except Federal Employee Program (FEP). Verify patient eligibility and inform patients of likely denial before scheduling subtalar arthroereisis procedures. For FEP members, ensure medical necessity documentation is complete.